Drug Database
Back to search

United States· US:71288-129_d9bb02eb-3f9e-4932-bdcd-53b5bd6392b6

Dactinomycin

A dactinomycin product containing dactinomycin, registered in United States by Meitheal Pharmaceuticals Inc.. The same ATC class is registered in 7 of our 19 countries.

ATC L01DA01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDactinomycinATCL01DA01REGISTER NO.US:71288-129_d9bb02eb…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dactinomycinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dactinomycin is registered in 7 of 19 countries.

Countries holding a registration under ATC L01DA01 (dactinomycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose
Search dactinomycin products by name

Dactinomycin · ATC L01DA01

7 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DACTINOMYCIN
Manufacturer
Meitheal Pharmaceuticals Inc.
Country
United States (US)
ATC code
L01DA01
ATC class
Dactinomycin
Defined daily dose
0.32 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7128812902
    1 VIAL, SINGLE-DOSE in 1 CARTON (71288-129-02) / 1 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    71288-129-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

163 interactions on record for dactinomycin.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dactinomycin against other medicinesHow interaction checks work

Dactinomycin · interactions on record

163 records

  • 30 severe
  • 83 moderate
  • 15 minor
  • 35 info

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dactinomycin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dactinomycin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Lyovac-Cosmegen
  • France · Cosmegen
  • Italy · Cosmegen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b400d452-0130-425b-9686-7094d159bfa7
GET /v1/drugs/b400d452-0130-425b-9686-7094d159bfa7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": ".5",
  "substance": "DACTINOMYCIN",
  "productndc": "71288-129",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA213463",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about dactinomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console